Ordinary Shares SEC Reporting - Current
Verified Company Profile 8/03/2016
Contact Info
  • 615 - 800 West Pender Street
  • Vancouver, BC V6C 2V6
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2015 20-F
CIK 0001355736
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o
Incorporated In: British Columbia, Canada
Year of Inc. 2000
Employees Not Available
Company Officers/Contacts
Arun Nayyar CEO
Oksana Novakovska Controller
Kam Thindal IR
Company Directors
Eugene Beukman
David Hall
Bob Rai
Company Notes
  • Formerly=Nuva Pharmaceuticals Inc. until 8-2014
  • Formerly=Alda Pharmaceuticals Corp. until 7-2013
Service Providers
Accounting/Auditing Firm
Smythe Ratcliffe
7th Flr-355 Burrard St
Vancouver, BC, V6G 2G8

Legal Counsel
Sangra Moller LLP
1000 Cathedral Place
925 West Georgia Street
Vancouver, BC, V6C 3L2

Investor Relations Firm
Pure Advertising & Marketing Inc
15132 68th Avenue
Vancouver, BC, V6C 2G8

NUVPD Security Details
Share Structure
Market Value1 Not Available
Authorized Shares Not Available
Outstanding Shares Not Available
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Shareholders of Record Not Available
Non US Stock Exchange Listing
VANC - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 0 (-100%)
Jun 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security